Status:
COMPLETED
Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort
Lead Sponsor:
University of Chile
Conditions:
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The investigators planned to examine a cohort of admitted patients at University of Chile Clinical Hospital with COVID-19 diagnosis. Authors report data on mortality, ICU admission, need of invasive m...
Detailed Description
This is a prospective cohort study of adult inpatients at University of Chile Clinical Hospital, located in Santiago, Chile. We enrolled all patients aged over 18 years detected with COVID-19 admitted...
Eligibility Criteria
Inclusion
- Patients over 18 years
- Diagnosis of COVID-19 defined by clinical findings of acute respiratory illness (as per WHO guidelines) together with i) a positive result on reverse transcriptase chain reaction polymerase (RT-PCR) assay performed on a nasopharyngeal swab; and/or ii) chest computed tomography (CT) with typical findings of COVID-19 and absence of an alternative diagnosis
Exclusion
- Length of hospital stay less than 24 hours
- Nosocomial SARS-CoV-2 infection
- Asymptomatic patients admitted for causes not related to coronavirus infection regardless their admission RT-PCR result
Key Trial Info
Start Date :
March 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2020
Estimated Enrollment :
395 Patients enrolled
Trial Details
Trial ID
NCT04758039
Start Date
March 13 2020
End Date
July 10 2020
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico de la Universidad de Chile
Santiago, Santiago Metropolitan, Chile